Swtching to "green" inhalers for conditions such as asthma could cut greenhouse gas emissions and reduce drug costs, a study suggests.
AstraZeneca has signed a 239 million US dollar (£186 million) deal to sell a revenue-generating anti-psychotic drug as it bids to move away from mature treatments and invest in innovation.
Brazil's president has launched a strong defence of his far-right government while on a visit to Saudi Arabia, blasting any criticism of his policies on recent fires in the Amazon region.
Warner to invest heavily on programming from its channels along with new fare to try and convince people to subscribe to the most expensive service.
German pharmaceutical giant Bayer reported on Wednesday that the number of US plaintiffs suing over weed killer Roundup has more than doubled over the past three months, reaching 42,700. Bayer has blamed the explosive growth of lawsuits on massive spending on TV advertising by lawyers seeking new plaintiffs over controversial active ingredient glyphosate. The number...
Conservationists fear hundreds of koalas have died in wildfires that have razed prime habitat on Australia's east coast.
Passport and banknote maker De La Rue continued its freefall on Wednesday as bosses issued a second profit warning in five months.
